INX IMCD N.V.

Shareholders meeting IMCD N.V. adopts all resolutions

Shareholders meeting IMCD N.V. adopts all resolutions

ROTTERDAM, The Netherlands (30 June 2020) – IMCD N.V. (hereafter “IMCD” or the “Company”) announces that all resolutions proposed to the shareholders at the Company’s Annual General Meeting (“AGM”) held today were adopted. This includes the adoption of the financial statements for the year 2019 and approval of the dividend proposal of EUR 0.90 per share in cash. The dividend calendar is as follows:

Thursday 2 July 2020 - Ex-dividend date

Friday 3 July 2020 - Record date

Monday 6 July 2020 - Payment date



Please find attached the full press release.



Attachment

EN
30/06/2020

Underlying

INXIMCD N.V.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IMCD N.V.

 PRESS RELEASE
Free
INX IMCD N.V.

IMCD to acquire TECOM Ingredients to strengthen its offering in the fo...

IMCD to acquire TECOM Ingredients to strengthen its offering in the food & nutrition market in Spain Rotterdam, The Netherlands (16 May 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, has signed an agreement to acquire 100% of the shares in TECOM Ingredients S.A. (“TECOM”). Founded in 1996 and headquartered in Molins de Rei, near Barcelona, Spain, TECOM is a recognised distributor of ingredients and additives to the food industry. The company is a trusted partner for customers active in the food...

May 16, 2025 1 EN
Quirijn Mulder ... (+2)
  • Quirijn Mulder
  • Stijn Demeester
INX IMCD N.V.

IMCD/Good start, valuation attractive/BUY

After surprisingly good numbers 1Q25, we believe there is more upside but 1Q has the easiest comp. Also, trade tariffs might disturb the distribution chain of chemicals. Overall, we modestly adjust our estimates for FY25-27, but we do not change our BUY rating. IMCD is in excellent shape in our view – the company's track record in growth, value enhancement and M&A continues, and its strong asset light model is intact. The share price fall since December has led to 18% lower multiples, suggesting...

05/16/25 May 16, 2025 1 EN
Free Trial
INX IMCD N.V.

IMCD NV: 1 director

A director at IMCD NV bought 840 shares at 118.690EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

05/09/25 May 9, 2025 1 EN
Guy Sips ... (+6)
  • Guy Sips
  • Kristof Samoy
  • Michiel Declercq
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Lewi
WKL Wolters Kluwer ...
ARCAD ARCADIS NV ... (+8)

Morning Notes : AALB NA, AD NA, ARCAD NA, SMAR BB, WKL NA, AZE BB, CTP...

: AALB NA, AD NA, ARCAD NA, SMAR BB, WKL NA, AZE BB, CTPNV NA, IMCD NA

WKL WOLTERS KLUWER NV
ARCAD ARCADIS NV
AALB AALBERTS N.V.
INX IMCD N.V.
AD KONINKLIJKE AHOLD DELHAIZE N.V.
SPEC SMARTPHOTO GROUP
AZE AZELIS GROUP NV
CTPNV CTP NV
05/07/25 May 7, 2025 1 EN
Thibault Leneeuw
  • Thibault Leneeuw
INX IMCD N.V.

IMCD Short-term revisions in light of the uncertainty

In this note we adjust our numbers to reflect the increased uncertainty which results in lower organic growth for FY25 and FY26. While the Gross Profit margin remained robust, OpEx was well above expectations across all regions. Due to these dynamics we lower our forecasted FY25 EBITA by 6% to € 548m. Furthermore, we dive into the divergence with Azelis as this stood out in 1Q25. Our adjustments result in a lower valuation of € 147 per share. Given the upside we maintain our Accumulate recommend...

05/07/25 May 7, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch